SCHEMBL6222285

SCHEMBL6222285

CC[CH]CCCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11758638 0.88
SCHEMBL228135 0.80
SCHEMBL11203071 0.79 TSHR (0.33)
SCHEMBL11625872 0.79
SCHEMBL4600942 0.79
SCHEMBL22445024 0.76 TSHR (0.38)
SCHEMBL8405 0.73
SCHEMBL27750523 0.73
SCHEMBL8439238 0.73
SCHEMBL13480708 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102531946-A 3-methoxybenzamide (MBA) derivant as well as preparation method and application thereof UNIV SHANDONG 2012-07-04 CN claimed
CN-102531946-A 3-methoxybenzamide (MBA) derivant as well as preparation method and application thereof UNIV SHANDONG 2012-07-04 CN disclosed
EP-1411942-A4 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2005-01-26 EP disclosed
CN-1155631-C Polymeric compounds 2004-06-30 CN disclosed
EP-1411942-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS Synaptic Pharmaceutical Corporation (US) 2004-04-28 EP disclosed
WO-2003004027-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-01-16 WO disclosed
CN-1360603-A Compound (I) ROLIC AG (CH) 2002-07-24 CN disclosed
EP-0139560-A1 Aqueous composition for dispersing hydrophobic substances,in particular suitable for cleaning objects soiled by paint or the like SOCIETE NATIONALE ELF AQUITAINE (FR) 1985-05-02 EP disclosed